Skip to main content


Log in

Remote monitoring of implantable cardiac devices in heart failure patients: a systematic review and meta-analysis of randomized controlled trials

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript


This study aims to determine whether the use of remote monitoring (RM) in implantable cardiac devices decreases all-cause mortality and heart failure (HF)-related hospitalization. We sought to conduct a systematic review and a meta-analysis of published randomized controlled studies. The population is adult patients with a diagnosis of HF with implantable devices. The intervention is RM using implantable cardiac devices whether added or used alone compared to standard of care. The outcomes are HF-related hospitalization and all-cause mortality. Risk of bias was assessed using the criteria defined in the Revised Cochrane Collaboration’s tool for assessment of risk of bias. Data were extracted and validity was assessed independently by two reviewers. Electronic databases EMBASE and MEDLINE (Ovid) were searched up to 14th of October 2019, supplemented by a second search in CENTRAL (Cochrane Central Register of Controlled Trials) and Only randomized controlled studies published in peer-reviewed journals with full format text in English of adult HF patients with a minimum follow-up of 6 months reporting mortality and/or hospitalization. Observational studies and studies that did not meet inclusion criteria were excluded. Thirteen randomized controlled studies that enrolled a total of 7015 patients were identified, 7 of which reported on all-cause mortality only and included 4460 patients. Compared with standard of care, the pooled relative risk (RR) of all-cause mortality and HF-related hospitalization in patients with RM compared to those receiving standard of care was 0.88 (95% confidence interval (CI) 0.69 to 1.11) and 0.95 (95% CI 0.78–1.16), respectively. In the subgroup analysis, using pulmonary pressure for RM was associated with a decrease in HF-related hospitalization (RR 0.73; 95% CI 0.60–0.88). RM showed benefit in reducing HF-related hospitalization when compared to standard of care only when using pulmonary pressure monitoring.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others


  1. Ponikowski P et al (2016) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail 18(8):891–975

    Article  Google Scholar 

  2. Ambrosy AP et al The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. (1558–3597 (Electronic))

  3. Mozaffarian D Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review. (1524–4539 (Electronic))

  4. Levy D et al Long-term trends in the incidence of and survival with heart failure. (1533–4406 (Electronic))

  5. Heidenreich Pa Fau - Albert NM et al Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. (1941–3297 (Electronic))

  6. Varma N et al The relationship between level of adherence to automatic wireless remote monitoring and survival in pacemaker and defibrillator patients. (1558–3597 (Electronic))

  7. Young GD (2012) Remote monitoring for implantable cardiac electronic devices. Heart Lung Circ 21(6):352–357

    Article  Google Scholar 

  8. Jermyn R, Alam A, Kvasic J, Saeed O, Jorde U (2017) Hemodynamic-guided heart-failure management using a wireless implantable sensor: infrastructure, methods, and results in a community heart failure disease-management program. Clin Cardiol 40(3):170–176

    Article  Google Scholar 

  9. Parthiban N et al Remote monitoring of implantable cardioverter-defibrillators: a systematic review and meta-analysis of clinical outcomes. (1558–3597 (Electronic))

  10. Adamson PB et al (2017) Remote haemodynamic-guided care for patients with chronic heart failure: a meta-analysis of completed trials. Eur J Heart Fail 19(3):426–433

    Article  Google Scholar 

  11. Dickinson MG et al (2018) Remote monitoring of patients with heart failure: a white paper from the Heart Failure Society of America scientific statements committee. J Card Fail 24(10):682–694

    Article  Google Scholar 

  12. Moher D et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4(1):1

    Article  Google Scholar 

  13. Klersy C et al A meta-analysis of remote monitoring of heart failure patients. (1558–3597 (Electronic))

  14. Pandor A et al (2013) Remote monitoring after recent hospital discharge in patients with heart failure: a systematic review and network meta-analysis. Heart 99(23):1717

    Article  Google Scholar 

  15. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev 5(1):210–210

    Article  Google Scholar 

  16. DerSimonian R Fau - Laird N, Laird N Meta-analysis in clinical trials. (0197–2456 (Print))

  17. Higgins JP, Thompson SG Quantifying heterogeneity in a meta-analysis. (0277–6715 (Print))

  18. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ

  19. Green S et al (2008) Cochrane handbook for systematic reviews of interventions. West Sussex, England, Wiley

    Google Scholar 

  20. Moher D et al Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (1549–1676 (Electronic))

  21. Adamson PB, Gold MR, Bennett T, Bourge RC, Stevenson LW, Trupp R, Stromberg K, Wilkoff BL, Costanzo MR, Luby A, Aranda JM, Heywood JT, Baldwin HA, Aaron M, Smith A, Zile M (2011) Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of the reducing decompensation events utilizing Intracardiac pressures in patients with chronic heart failure (REDUCEhf) trial. Congest Heart Fail 17(5):248–254

    Article  Google Scholar 

  22. Al-Khatib SM et al (2010) Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial. J Cardiovasc Electrophysiol 21(5):545–550

    Article  Google Scholar 

  23. Abraham WT et al Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. (1474-547X (Electronic))

  24. Boriani G, da Costa A, Quesada A, Ricci RP, Favale S, Boscolo G, Clementy N, Amori V, Mangoni di S Stefano L, Burri H, MORE-CARE Study Investigators (2017) Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial. Eur J Heart Fail 19(3):416–425

    Article  Google Scholar 

  25. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW, COMPASS-HF Study Group (2008) Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 51(11):1073–1079

    Article  Google Scholar 

  26. Domenichini G et al (2015) The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study). EP Europace 18(3):428–435

    Article  Google Scholar 

  27. Hansen C, Loges C, Seidl K, Eberhardt F, Tröster H, Petrov K, Grönefeld G, Bramlage P, Birkenhauer F, Weiss C (2018) INvestigation on routine follow-up in CONgestive HearT FAilure patients with remotely monitored implanted Cardioverter defibrillators SysTems (InContact). BMC Cardiovasc Disord 18(1):131

    Article  Google Scholar 

  28. Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, Brachmann J, Lewalter T, Goette A, Block M, Kautzner J, Sack S, Husser D, Piorkowski C, Søgaard P, IN-TIME study group* (2014) Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet 384(9943):583–590

    Article  Google Scholar 

  29. Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A, Parati G, Borghi G, Zanaboni P, Valsecchi S, Marzegalli M (2012) Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators. Circulation 125(24):2985–2992

    Article  Google Scholar 

  30. Luthje L et al A randomized study of remote monitoring and fluid monitoring for the management of patients with implanted cardiac arrhythmia devices. (1532–2092 (Electronic))

  31. Morgan JM, Kitt S, Gill J, McComb J, Ng GA, Raftery J, Roderick P, Seed A, Williams SG, Witte KK, Wright DJ, Harris S, Cowie MR (2017) Remote management of heart failure using implantable electronic devices. Eur Heart J 38(30):2352–2360

    Article  Google Scholar 

  32. van Veldhuisen DJ et al Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. (1524–4539 (Electronic))

  33. Varma N, Epstein AE, Irimpen A, Schweikert R, Love C, TRUST Investigators (2010) Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up. Circulation 122(4):325–332

    Article  Google Scholar 

  34. Tse G, Chan C, Gong M, Meng L, Zhang J, Su XL, Ali-Hasan-al-Saegh S, Sawant AC, Bazoukis G, Xia YL, Zhao JC, Lee APW, Roever L, Wong MC, Baranchuk A, Liu T, International Health Informatics Study (IHIS) Network (2018) Telemonitoring and hemodynamic monitoring to reduce hospitalization rates in heart failure: a systematic review and meta-analysis of randomized controlled trials and real-world studies. J Geriatr Cardiol 15(4):298–309

    PubMed  PubMed Central  Google Scholar 

Download references


We would like to thank Yang Chen and Mario Santos for their comments on a previous version of this paper as well on the search strategy.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Bernardo A. Perez.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material


(DOCX 423 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alotaibi, S., Hernandez-Montfort, J., Ali, O.E. et al. Remote monitoring of implantable cardiac devices in heart failure patients: a systematic review and meta-analysis of randomized controlled trials. Heart Fail Rev 25, 469–479 (2020).

Download citation

  • Published:

  • Issue Date:

  • DOI: